Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDA-I: Polyglucoferron for Preoperative Iron Deficiency Anaemia
NCT04087993Phase 3Withdrawn
- Sponsor
- Dr. Frank Behrens
- Start
- May 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in iron deficiency anemia (IDA) (3 arms), sponsored by Dr. Frank Behrens. Primary endpoints: Normalisation or Increase of hemaglobin(Hb)-level and Detection of urine iron. Planned start May 2020; status: withdrawn.
02
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04087993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04087993.